{
  "id": "septic_shock_vasopressors_selectAll_v1",
  "type": "selectAll",
  "stem": "The nurse is titrating norepinephrine for a client in septic shock who remains hypotensive after a 30 mL/kg fluid bolus. Which nursing actions are priorities for the safe administration of this medication? Select all that apply.",
  "options": [
    {
      "id": "a",
      "text": "Maintain the Mean Arterial Pressure (MAP) at ≥65 mmHg."
    },
    {
      "id": "b",
      "text": "Assess the infusion site every 15-30 minutes for signs of extravasation."
    },
    {
      "id": "c",
      "text": "Administer the medication through a large-bore peripheral IV indefinitely."
    },
    {
      "id": "d",
      "text": "Monitor for signs of peripheral ischemia (cold, pale digits)."
    },
    {
      "id": "e",
      "text": "Ensure phentolamine is available on the unit for potential extravasation."
    },
    {
      "id": "f",
      "text": "Discontinue the infusion immediately once the target BP is reached."
    }
  ],
  "correctOptionIds": [
    "a",
    "b",
    "d",
    "e"
  ],
  "scoring": {
    "method": "plus-minus",
    "maxPoints": 4
  },
  "pedagogy": {
    "bloomLevel": "apply",
    "cjmmStep": "takeAction",
    "nclexCategory": "Pharmacological and Parenteral Therapies",
    "difficulty": 4,
    "topicTags": [
      "Septic Shock",
      "Vasopressors",
      "Critical Care",
      "Pharmacology",
      "Norepinephrine"
    ]
  },
  "answerBreakdown": {
    "a": {
      "isCorrect": true,
      "content": "Correct. Septic shock is characterized by profound vasodilation due to the overwhelming inflammatory response. Inflammatory mediators such as nitric oxide and cytokines cause vascular smooth muscle relaxation, leading to a drastic reduction in Systemic Vascular Resistance (SVR). This results in severe hypotension, compromising perfusion to vital organs. A MAP below 65 mmHg indicates inadequate blood flow to the heart, brain, and kidneys, potentially leading to organ damage or failure. Norepinephrine, a potent alpha-1 adrenergic agonist, stimulates vasoconstriction, increasing SVR and raising MAP. Titrating norepinephrine to maintain a MAP ≥65 mmHg ensures adequate oxygen and nutrient delivery to vital organs. Clinical Pearl: Hypotension refractory to fluid resuscitation is a hallmark of septic shock, necessitating vasopressor support to maintain adequate perfusion pressure. SBAR: Situation: Patient in septic shock, hypotensive despite fluid bolus. Background: Septic shock causes vasodilation and decreased SVR. Assessment: MAP is below target. Recommendation: Titrate norepinephrine to maintain MAP ≥65 mmHg. Time: 1400."
    },
    "b": {
      "isCorrect": true,
      "content": "Correct. Norepinephrine is a vesicant, meaning it can cause severe tissue damage if it leaks out of the vein (extravasation). Norepinephrine's potent alpha-1 adrenergic agonist action causes intense vasoconstriction of the small vessels in the subcutaneous tissue surrounding the IV site. This vasoconstriction reduces or completely cuts off local blood flow, leading to rapid tissue ischemia, hypoxia, and subsequent necrosis if not treated promptly. Extravasation can lead to skin breakdown, ulceration, and even the need for surgical debridement or skin grafting. Frequent assessment of the IV site (every 15-30 minutes) for signs of extravasation (coolness, pallor, swelling, pain, or burning) is crucial for early detection and intervention. Clinical Pearl: Use a central line for vasopressor administration whenever possible to minimize the risk of extravasation. If a peripheral line is used, ensure it is a large-bore IV in a large vein, and monitor the site meticulously. SBAR: Situation: Norepinephrine infusion in progress. Background: Norepinephrine is a vesicant. Assessment: Requires frequent monitoring for extravasation. Recommendation: Assess IV site every 15-30 minutes. Time: 1400."
    },
    "c": {
      "isCorrect": false,
      "content": "Incorrect. While a large-bore peripheral IV may be used for *initial* norepinephrine administration in an emergency when central venous access is not immediately available, it is *not* appropriate for indefinite use. Peripheral veins are smaller and have lower blood flow compared to central veins, increasing the risk of mechanical dislodgement, phlebitis, and extravasation. The standard of care is to administer vasopressors via a central venous catheter, which terminates in a large, high-flow vessel (e.g., superior vena cava). This allows for rapid hemodilution of the medication, minimizing vascular irritation and the catastrophic consequences of extravasation. Clinical Pearl: Central venous access is the preferred route for vasopressor administration due to the lower risk of complications. SBAR: Situation: Norepinephrine infusing via peripheral IV. Background: Peripheral IV increases risk of extravasation. Assessment: Peripheral IV in place. Recommendation: Obtain central venous access as soon as possible. Time: 1400."
    },
    "d": {
      "isCorrect": true,
      "content": "Correct. Norepinephrine's therapeutic effect of increasing SVR is achieved by potent peripheral vasoconstriction. This vasoconstriction shunts blood from the periphery (skin, extremities, gut) to the vital central organs (heart, brain, kidneys) to maintain perfusion to these critical areas. A direct consequence of this shunting is reduced perfusion to the distal extremities. High doses or prolonged use of norepinephrine can lead to severe ischemia, manifesting as cold, pale, cyanotic, or mottled fingers and toes. In severe cases, this can progress to gangrene and limb loss. Monitoring for signs of peripheral ischemia (assessing skin color, temperature, and pulses in the extremities) is a priority to detect early signs of compromised perfusion and prevent irreversible tissue damage. Clinical Pearl: Monitor peripheral perfusion closely during norepinephrine administration, and report any signs of ischemia immediately. SBAR: Situation: Norepinephrine infusion in progress. Background: Norepinephrine causes peripheral vasoconstriction. Assessment: Requires monitoring for peripheral ischemia. Recommendation: Monitor extremities for color, temperature, and pulses. Time: 1400."
    },
    "e": {
      "isCorrect": true,
      "content": "Correct. Phentolamine is the specific antidote for norepinephrine extravasation. It is an alpha-adrenergic antagonist that directly counteracts norepinephrine's vasoconstrictive effects at the site of infiltration. By competitively blocking the alpha-1 receptors on vascular smooth muscle, phentolamine induces local vasodilation, restoring blood flow to the ischemic tissue, and preventing or minimizing tissue necrosis. Phentolamine should be readily available on the unit whenever norepinephrine is being administered, and treatment should be initiated within minutes to hours of the extravasation event to be effective. Clinical Pearl: Phentolamine should be injected subcutaneously around the area of extravasation to reverse the vasoconstrictive effects of norepinephrine. SBAR: Situation: Norepinephrine infusion in progress. Background: Risk of extravasation. Assessment: Phentolamine should be readily available. Recommendation: Ensure phentolamine is available on the unit. Time: 1400."
    },
    "f": {
      "isCorrect": false,
      "content": "Incorrect. Abruptly discontinuing a norepinephrine infusion can cause severe rebound hypotension. Prolonged stimulation of adrenergic receptors by the infusion can lead to their downregulation or desensitization. The client's vascular tone becomes dependent on the exogenous norepinephrine. Suddenly stopping the drug removes this support, and the desensitized endogenous system cannot compensate quickly, leading to a precipitous drop in SVR and blood pressure. This can result in life-threatening hypoperfusion of vital organs. The norepinephrine infusion must be tapered slowly, allowing the body's own catecholamine system and receptor sensitivity to recover and maintain hemodynamic stability. Clinical Pearl: Norepinephrine should always be tapered gradually to avoid rebound hypotension. SBAR: Situation: Client receiving norepinephrine. Background: Abrupt discontinuation can cause rebound hypotension. Assessment: Requires slow tapering of norepinephrine. Recommendation: Do not discontinue norepinephrine abruptly; taper slowly. Time: 1400."
    }
  },
  "questionTrap": "The primary trap is distinguishing between emergency, short-term actions and the definitive standard of care. While a peripheral IV might be used to initiate norepinephrine in a crisis, the word 'indefinitely' makes it incorrect and dangerous. The NGN candidate must recognize that vasopressors require central line access as soon as feasible to mitigate the severe risk of tissue necrosis from extravasation. This highlights the critical thinking required to balance immediate life-saving interventions with long-term safety protocols.",
  "mnemonics": "Use the mnemonic 'SCAN' for norepinephrine safety priorities:\n\n*   **S**ite: Assess site frequently for extravasation; secure a **S**uperior Vena Cava (central) line ASAP.\n*   **C**irculation: Maintain MAP ≥65 mmHg for vital organ perfusion; check distal **C**irculation for ischemia (cold digits).\n*   **A**ntidote: Ensure phentolamine is **A**vailable.\n*   **N**ever stop abruptly: Titrate and wean slowly to prevent rebound hypotension.",
  "sentinelStatus": "healed_v2026_v8"
}